AbCellera Biologics Inc. (ABCL) Operating margin 2019–2025
AbCellera Biologics Inc. (ABCL) operating margin by fiscal year — reported operating income divided by reported revenue.
-289.0%FY2025 · since FY2019: -35.5% → -289.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -289.0% | +802.7 pp |
| FY2024 | -1091.7% | -467.9 pp |
| FY2023 | -623.8% | -668.4 pp |
| FY2022 | 44.6% | -9.9 pp |
| FY2021 | 54.5% | -12.4 pp |
| FY2020 | 66.9% | +102.4 pp |
| FY2019 | -35.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice